Century Therapeutics (IPSC) Retained Earnings (2020 - 2026)
Century Therapeutics (IPSC) reported Retained Earnings of -$813.6 million for Q1 2026, down 15.27% year-over-year from -$960.2 million in Q1 2025, and down 2711973.33% quarter-over-quarter from $30000.0 in Q4 2025.
Century Therapeutics (IPSC) Retained Earnings (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has 7 years of Retained Earnings data on file, last reported at -$813.6 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$813.6 million, down 15.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$813.6 million (down 15.27% YoY), and the FY2025 annual result was $30000.0, up 100.0% from the prior year.
- Retained Earnings fell to -$813.6 million in Q1 2026 per IPSC's latest filing, from $30000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $758000.0 in Q3 2024 and troughed at -$813.6 million in Q1 2026.
- A 5-year average of -$317.3 million and a median of -$3.4 million in 2022 frame the typical range for Retained Earnings.
- On a YoY basis, Retained Earnings climbed as much as 126.86% in 2025 and fell as far as 292753.53% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$2.5 million in 2022, then tumbled by 26535.7% to -$655.8 million in 2023, then fell by 19.3% to -$782.3 million in 2024, then surged by 100.0% to $30000.0 in 2025, then plunged by 2711973.33% to -$813.6 million in 2026.
- Business Quant data shows IPSC's Retained Earnings at -$813.6 million in Q1 2026, $30000.0 in Q4 2025, and -$772.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Century Therapeutics | 444.99 Mn | 444.99 Mn | - | -813.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -813.56 Mn |
| Dec 31, 2025 | 30,000.00 |
| Sep 30, 2025 | -772.74 Mn |
| Jun 30, 2025 | 83,000.00 |
| Mar 31, 2025 | -705.78 Mn |
| Dec 31, 2024 | -782.34 Mn |
| Sep 30, 2024 | 758,000.00 |
| Jun 30, 2024 | -309,000.00 |
| Mar 31, 2024 | -241,000.00 |
| Dec 31, 2023 | -655.77 Mn |
| Sep 30, 2023 | -616.37 Mn |
| Jun 30, 2023 | -1.21 Mn |
| Mar 31, 2023 | -550.36 Mn |
| Dec 31, 2022 | -2.46 Mn |
| Sep 30, 2022 | -487.42 Mn |
| Jun 30, 2022 | -3.43 Mn |
| Mar 31, 2022 | -2.64 Mn |
| Dec 31, 2021 | -388.17 Mn |
| Sep 30, 2021 | -359.97 Mn |
| Jun 30, 2021 | -333.96 Mn |